Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?
Journal of Child and Adolescent Psychopharmacology · 01.08.2026 · 36 (6) · 384-385
DOI: 10.1177/10445463261454151 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 20.05.2026. Verfasst von Maryam Tariq und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, The University of Kansas Medical Center, Overland Park, Kansas, USA. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Child and Adolescent Psychiatry, The University of Kansas Medical Center, Overland Park, Kansas, USA.
ORCID-Profile: Maryam Tariq
Zitieren
APA
Tariq, M., & Genovese, A. (2026). Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?. Journal of Child and Adolescent Psychopharmacology, 36(6), 384-385. https://doi.org/10.1177/10445463261454151
Vancouver
Tariq M, Genovese A. Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?. Journal of Child and Adolescent Psychopharmacology. 2026;36(6):384-385. doi:10.1177/10445463261454151
BibTeX
@article{Tariq2026,
author = {Tariq, Maryam and Genovese, Ann},
title = {Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2026},
volume = {36},
number = {6},
pages = {384--385},
doi = {10.1177/10445463261454151}
}
EUVIMED